Aditxt, Inc. Interest Expense, Other Long-term Debt
Aditxt, Inc. (ADTX) reported Interest Expense, Other Long-term Debt of $1.52 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOtherLongTermDebt · last filed 2023-08-14
- Aditxt, Inc. interest expense, other long-term debt for the quarter ending 2023-06-30 was $1.33M.
- Aditxt, Inc. interest expense, other long-term debt for the quarter ending 2023-03-31 was $193.18K.
- Aditxt, Inc. interest expense, other long-term debt for fiscal 2022 was $753.04K, a 4669.38% increase from fiscal 2021.
- Aditxt, Inc. interest expense, other long-term debt for fiscal 2021 was $15.79K.
| Period end | Interest Expense, Other Long-term Debt 3 month | Interest Expense, Other Long-term Debt 6 month | Interest Expense, Other Long-term Debt 12 month |
|---|---|---|---|
| 2023-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.52M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $193.18K 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | $753.04K 10-K · filed 2023-04-17 | ||
| 2022-06-30 | $70.83K 10-Q · filed 2023-08-14 | ||
| 2021-12-31 | $15.79K 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |